Department of Internal Medicine, Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH, 44195, USA.
Division of Gastroenterology and Hepatology, Cleveland Clinic Foundation, Cleveland, USA.
Dig Dis Sci. 2020 Jan;65(1):269-275. doi: 10.1007/s10620-019-05725-0. Epub 2019 Jul 12.
Prior studies have shown that about 90% of all carcinoid tumors occur in the GI tract. However, epidemiological studies of these tumors have been limited by small sample size. Our aim was to obtain a more robust epidemiologic survey of large bowel carcinoids (LBC), using population-based data in order to more accurately identify risk factors for these tumors.
We used a commercial database (Explorys Inc, Cleveland, OH) which includes electronic health record data from 26 major integrated US healthcare systems. We identified all patients aged 18 and older who were diagnosed with LBC, excluding appendiceal carcinoids, between 1999 and 2018 based on Systematized Nomenclature Of Medicine-Clinical Terms (SNOMED-CT) and evaluated the prevalence of LBC. We also performed univariate analysis to describe age-, race-, and gender-based distributions and to identify potential risk factors.
Of the 62,817,650 individuals in the database, 4530 were identified to have LBC with an overall prevalence of 7.21/100,000. Individuals with LBC were more likely to be elderly (age > 65) [OR 2.17, CI 2.05-2.31, p < 0.0001], smokers [OR 3.25; 95% CI 3.00-3.53, p < 0.0001], have a history of alcohol use [OR 3.75; 95% CI 3.52-3.99, p < 0.0001], diabetes mellitus (DM) [OR 4.42; 95% CI 4.14-4.72, p < 0.0001], obesity [OR 1.58; 95% CI 1.43-1.74, p < 0.0001], family history of cancer [OR 8.06; 95% CI 7.47-8.71, p < 0.0001], and personal history of ulcerative colitis [OR 6.93; 95% CI 5.55-8.64, p < 0.0001] or Crohn's disease [OR 6.45; 95% CI 5.24-7.95, p < 0.0001]. The prevalence of LBC was less among Caucasians compared to African-Americans [OR 0.57; 95% CI 0.53-0.61, p < 0.0001]. There was no statistically significant gender-based difference; men versus women [OR 1.02; 95% CI 0.96-1.08, p = 0.47]. The most common presenting symptoms included flushing, diarrhea, nausea, weight loss, and abdominal pain, while the most common GI associations included perforation, obstruction, hemorrhage, intussusception, and volvulus.
This is the largest epidemiological study evaluating the prevalence of LBC. We estimated the prevalence rate of LBC to be 7.21/100,000. The presence of significant risk factors with the clinical picture suspicious for a LBC should warrant thorough evaluation as these tumors can lead to life-threatening complications. Further studies are needed to better understand the mechanism of association between these risk factors and LBC.
先前的研究表明,约 90%的类癌肿瘤发生在胃肠道。然而,这些肿瘤的流行病学研究受到样本量小的限制。我们的目的是使用基于人群的数据获得更准确的大肠类癌(LBC)的更具代表性的流行病学调查结果,以便更准确地确定这些肿瘤的危险因素。
我们使用了一个商业数据库(位于俄亥俄州克利夫兰的 Explorys Inc),其中包含来自 26 个主要美国综合医疗系统的电子健康记录数据。我们根据系统命名法医学临床术语(SNOMED-CT),从 1999 年至 2018 年确定了所有年龄在 18 岁及以上的 LBC 患者(不包括阑尾类癌),并评估了 LBC 的患病率。我们还进行了单变量分析,以描述年龄、种族和性别分布,并确定潜在的危险因素。
在数据库的 62817650 人中,有 4530 人被诊断为 LBC,总体患病率为 7.21/100000。患有 LBC 的人更有可能是老年人(年龄>65 岁)[比值比 2.17,95%置信区间 2.05-2.31,p<0.0001]、吸烟者[比值比 3.25;95%置信区间 3.00-3.53,p<0.0001]、有饮酒史[比值比 3.75;95%置信区间 3.52-3.99,p<0.0001]、糖尿病[比值比 4.42;95%置信区间 4.14-4.72,p<0.0001]、肥胖[比值比 1.58;95%置信区间 1.43-1.74,p<0.0001]、有癌症家族史[比值比 8.06;95%置信区间 7.47-8.71,p<0.0001]或溃疡性结肠炎[比值比 6.93;95%置信区间 5.55-8.64,p<0.0001]或克罗恩病[比值比 6.45;95%置信区间 5.24-7.95,p<0.0001]。与非裔美国人相比,白种人患 LBC 的患病率较低[比值比 0.57;95%置信区间 0.53-0.61,p<0.0001]。性别之间没有统计学上的显著差异;男性与女性[比值比 1.02;95%置信区间 0.96-1.08,p=0.47]。最常见的表现症状包括潮红、腹泻、恶心、体重减轻和腹痛,而最常见的胃肠道关联包括穿孔、梗阻、出血、肠套叠和扭转。
这是评估 LBC 患病率的最大规模的流行病学研究。我们估计 LBC 的患病率为 7.21/100000。存在具有可疑 LBC 临床表现的显著危险因素时,应进行彻底评估,因为这些肿瘤可能导致危及生命的并发症。需要进一步研究以更好地了解这些危险因素与 LBC 之间的关联机制。